The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 25, 2025

Filed:

Aug. 29, 2018
Applicants:

Ose Immunotherapeutics, Nantes, FR;

Etablissement Francais Du Sang, La Plaine St Denis, FR;

Assistance Publique—hopitaux DE Paris, Paris, FR;

Inventors:

Bernard Vanhove, Reze, FR;

Nicolas Poirier, Treillieres, FR;

Sebastien Maury, Paris, FR;

Jose Cohen, Paris, FR;

Caroline Pilon, Saint Maurice, FR;

Brigitte Birebent, Yebles, FR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0087 (2013.01); A61K 39/4611 (2023.05); A61K 39/4621 (2023.05); A61K 39/464419 (2023.05); A61P 35/00 (2018.01); C07K 16/2866 (2013.01); C12N 5/0636 (2013.01);
Abstract

The invention relates to methods and preparations for sorting out T effector cells from human leukocytes using anti-CD127 antibodies. Accordingly the invention relates to the use of anti-CD127 antibodies enabling discriminative depletion of subpopulations of Tregulatory cells expressing CD127+ at low levels in a population of human T lymphocytes in order to enable the use of the recovered selected cell preparations comprising essentially Teffector cells as lymphocytes and preferably devoid of Tregulatory cells, for improved efficacy in particular when administered to a patient for therapy.


Find Patent Forward Citations

Loading…